Year 2023 / Volume 115 / Number 12
Letter
Carcinoid syndrome and somatostatin analogues

726-727

DOI: 10.17235/reed.2023.9525/2023

Modesto Varas Lorenzo,

Abstract
Clinical experience is herein reported with somatostatin analogues (octreotide and lanreotide) in the management of 10 CS out of a series of 14 collected cases of carcinoid syndrome (CS).
Share Button
New comment
Comments
No comments for this article
References
1. Varas MJ. Tratamiento farmacológico de los apudomas gastroenteropancreáticos con el análogo de la Somatostatina SMS 201-995 (Octreotide). Rev Esp Enferm Digestivas 1990; 79: 95-8.
2. Gade AK, Olariu E, Douthi NT. Carcinoid syndrome: A review. Cureus 2020; 12: e 7186. Doi: 10.7759/cureus.7186
3. Pandit S, Annamaraju P, Bhusal K. Carcinoid syndrome. Stat Pearls 2022.
4. Magi L, Rinzinillo M, Panzuto F, et al. What gastroenterologists should know about carcinoid syndrome. Gastroenterol Insights 2022; 13: 127-138. Doi.org/10.3390/gastroent13010014.
5. Hofland J, Herrera-Martinez AU, Zandee WT, de Herder WW. Management of carcinoid syndrome: a systematic review and meta-analysis. Endcr Relat Cancer 2019; 26: R145-R156. Doi: 10.1530/ERC-18-0495.
Related articles

Letter

Surgical indication of type I gastric neuroendocrine tumors

DOI: 10.17235/reed.2023.9681/2023

Digestive Diseases Image

Endoscopic resection of a duodenal neuroendocrine tumor

DOI: 10.17235/reed.2021.8232/2021

Digestive Diseases Image

A rare cause of extrahepatic biliary tract stricture: a neuroendocrine carcinoma

DOI: 10.17235/reed.2020.6491/2019

Case Report

Using octreotide for refractory ascites after liver transplantation

DOI: 10.17235/reed.2019.6316/2019

Letter to the Editor

Author´s reply: Cystic pancreatic neuroendocrine tumors. A diagnostic challenge

DOI: 10.17235/reed.2018.5415/2017

Letter to the Editor

Neuroendocrine tumors of the pancreas: keys issues in dealing with heterogeneity

DOI: 10.17235/reed.2017.4997/2017

Letter to the Editor

Pancreatic neuroendocrine tumors. Prognostic factors

DOI: 10.17235/reed.2017.5109/2017

Letter to the Editor

Pancreatic neuroendocrine tumors

DOI: 10.17235/reed.2017.4725/2016

Editorial

Pancreas neuroendocrine tumors - not so rare or benign

DOI: 10.17235/reed.2016.4672/2016

Citation tools
Varas Lorenzo M. Carcinoid syndrome and somatostatin analogues. 9525/2023


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 923 visits.
This article has been downloaded 96 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 12/02/2023

Accepted: 20/02/2023

Online First: 10/03/2023

Published: 12/12/2023

Article Online First time: 26 days

Article editing time: 303 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology